Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 18 or older
- You are able to carry out daily activities with little to no limitation (confirm with trial site)
- You have been diagnosed with breast cancer confirmed through a tissue or cell sample
- Tests have shown that cancer has spread to the lymph nodes in your armpit area
- You have already completed at least 3 rounds of treatment given before surgery (such as chemotherapy) and are planning to have surgery
- You are willing and able to sign a consent form to take part in the trial
Who may not be able to join:
- Your cancer has spread to other parts of the body beyond the breast and nearby lymph nodes
- You are unable to complete the planned course of treatment given before surgery
- You are currently pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaosong Chen, Shanghai Jiao Tong University, School of Medicine, Affiliated Ruijin Hospital
Phone: 86-21-64370045
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and specificity of 68Ga FAPI PET/CT in predicting residual axillary lymph node lesions after neoadjuvant therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.